Abstract Information

Submit an Abstract

Submit a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application by 5 p.m. PDT on Aug. 1, 2019. For more information, see the 2019 Regular and Late-Breaking Abstract Reference Guide or continue scrolling to learn more about specific abstract categories and timelines:

Important Abstract Dates

Regular and Late-Breaking

Date Details
April 9, 2019 Regular Abstracts, Young Investigator Award Abstracts, and Late-Breaking Abstracts Application Submission Site Opens
Aug. 1, 2019 Regular Abstracts, Young Investigator Award Abstracts, Late-Breaking Abstracts Application Site Closes at 5 p.m. PDT
Aug. 9, 2019 Late-Breaking Abstracts Application Notifications Sent
Aug. 23, 2019 Late-Breaking Abstract Submission Site Opens
Aug. 30, 2019 Regular Abstract and Young Investigator Award Abstract Notifications Sent
Sept. 6, 2019 Regular Abstract Presentation Acceptance Confirmations
Deadline for Regular Abstract Withdrawals and Changes
Sept. 12, 2019 Late-Breaking Abstract Submission Site Closes at 5 p.m. PDT
Sept. 23, 2019 Late-Breaking Abstract Notifications Sent
Sept. 30, 2019 Late-Breaking Abstract Presentation Acceptance Confirmation Due
Deadline for Late-Breaking Abstract Withdrawals and Changes
Oct. 1, 2019 Regular Abstract Title and Author Information Released
Nov. 1, 2019 Late-Breaking Abstract Title and Author Information Released
Nov. 5, 2019 Embargo Lifted and Full Regular and Late-Breaking Abstracts Made Public at 8 a.m. EST
Regular Abstract Supplement Published in JITC
Nov. 6 – 10, 2019 34th Annual Meeting & Pre-Conference Programs
Dec. 5, 2019 Late-Breaking Abstract Supplement Published in JITC

Abstract Information

Regular Abstract

Submit your latest research in the cancer immunotherapy field to the 34th Annual Meeting & Pre-Conference Programs (SITC 2019) for consideration as an oral abstract presentation, rapid oral abstract presentation, and/or poster abstract presentation from April 9, 2019 until 5 p.m. PDT on Aug. 1, 2019.

Late-Breaking Abstract

Late-breaking abstract (LBA) submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline.

All LBA submitters must submit an application by 5 p.m. PDT on Aug. 1, 2019 to be eligible for the LBA submission period. Applications will be reviewed and all submitters will be notified if they qualify to submit a late-breaking abstract during the submission period from Aug. 23, 2019 to 5 p.m. PDT on Sept. 12, 2019. If an application does not qualify for late-breaking abstract submission, the submitter will be notified by Aug. 9, 2019 and will have the opportunity to submit a regular abstract by 5 p.m. PDT on Aug. 14, 2019.

Late-breaking abstracts are considered for, but not limited to, oral abstract presentations during the Late-Breaking Abstract Sessions from 12 – 12:30 p.m. on Friday, Nov. 8, 2019 and 11:50 a.m. – 12:20 p.m. on Saturday, Nov. 9, 2019.

Young Investigator Award Abstract

Regular abstracts with primary and presenting authors that are students, postdoctoral research fellows, clinical fellows, or junior faculty with three or fewer years on staff and are current SITC members, may be eligible to receive a Young Investigator Award. Young Investigator Award abstracts require a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author.

Those selected for the Presidential Travel Award will be invited to give an oral abstract presentation during the Presidential Session from 2:05 – 3:30 p.m. on Saturday, Nov. 9, 2019.

For more information about the Young Investigator Awards as well as the criteria and eligibility, please click here.

Reasons to Submit an Abstract to SITC 2019

  • Free submission for members and nonmembers (View Important Submission Dates)
  • Young Investigator Awards are offered in conjunction with regular abstract submission
  • All accepted abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal
  • Multiple oral presentation opportunities available
  • The opportunity to present and discuss your research with luminaries in the immunotherapy field